1417 entries
1234 -IG
7 -TR
47 -FPIA
68 -CPCA
61 -RPI
1234 -IG
7 -TR
47 -FPIA
68 -CPCA
61 -RPI
IMGT/mAb-DB card
Version: 2.0.4 (2023-04-14)
Citing IMGT/mAb-DB
Manso T., Kushwaha A., Abdollahi N., Duroux P., Giudicelli V. and Kossida S. Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB. Front Immunol., 14 (2023). DOI 10.3389/fimmu.2023.1129323
Poiron C., Wu Y., Ginestoux C., Ehrenmann, Duroux P. and Lefranc M.-P.
IMGT/mAb-DB: the IMGT® database for therapeutic monoclonal antibodies.
JOBIM 2010, Paper 13 (2010).
Abstract
Cambon M., Cherouali K., Kushwaha A., Giudicelli V., Duroux P., Kossida S. and Lefranc M.-P.
IMGT/mAb-DB and IMGT/2Dstructure-DB for IMGT standard definition of an antibody: from receptor to amino acid changes.
JOBIM 2018, Poster 201 (2018).
Abstract
| IMGT/mAb-DB ID | 941 |
| INN | avizakimab |
| INN Number | 11148 |
| INN Prop. List | 121 (2019) |
| INN Rec. List | 83 (2020) |
| Common name | BOS161721 |
| Proprietary name | |
| Species | Humanized |
| IMGT receptor type | IG |
| Format (legend) |  |
| Receptor identification | IgG1 - kappa |
| Radiolabelled / Conjugated / Fused | |
| IMGT/2Dstructure-DB | 11148 |
| IMGT/3Dstructure-DB | |
| Specificity target name and species | IL21 (interleukin 21) [Humanized] |
| Development Technology | |
| Origin clone species | |
| Origin clone name | |
| Company | Boston Pharmaceuticals (Cambridge MA USA) |
| Expression system | CHO (Chinese Hamster Ovary) cells |
| Application | Therapeutic |
| Clinical domain | Immunology |
| Mechanism of action | |
| Clinical indication | Systemic lupus erythematosus (SLE) |
| Development status | Phase I/II |
| Regulatory agency status and year | |
| Clinical trials | |
| Authority decisions | |
| External links | |
| Biosimilars | |
Format legend:
© Copyright 1995-2023
IMGT®, the international ImMunoGeneTics information system®
| Terms of use
| About us
| Contact us
| Citing IMGT
